PL2882432T3 - Sposób leczenia trądziku - Google Patents

Sposób leczenia trądziku

Info

Publication number
PL2882432T3
PL2882432T3 PL13827298T PL13827298T PL2882432T3 PL 2882432 T3 PL2882432 T3 PL 2882432T3 PL 13827298 T PL13827298 T PL 13827298T PL 13827298 T PL13827298 T PL 13827298T PL 2882432 T3 PL2882432 T3 PL 2882432T3
Authority
PL
Poland
Prior art keywords
acne
treatment
Prior art date
Application number
PL13827298T
Other languages
English (en)
Inventor
Scott Lundahl
Original Assignee
Dusa Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dusa Pharmaceuticals, Inc. filed Critical Dusa Pharmaceuticals, Inc.
Publication of PL2882432T3 publication Critical patent/PL2882432T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0616—Skin treatment other than tanning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL13827298T 2012-08-10 2013-08-09 Sposób leczenia trądziku PL2882432T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261681888P 2012-08-10 2012-08-10
PCT/US2013/054263 WO2014026077A1 (en) 2012-08-10 2013-08-09 Method for the treatment of acne
EP13827298.4A EP2882432B1 (en) 2012-08-10 2013-08-09 Method for the treatment of acne

Publications (1)

Publication Number Publication Date
PL2882432T3 true PL2882432T3 (pl) 2020-07-13

Family

ID=50066728

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13827298T PL2882432T3 (pl) 2012-08-10 2013-08-09 Sposób leczenia trądziku

Country Status (7)

Country Link
US (2) US9387341B2 (pl)
EP (1) EP2882432B1 (pl)
AU (1) AU2013299487B2 (pl)
CA (1) CA2881439C (pl)
ES (1) ES2778031T3 (pl)
PL (1) PL2882432T3 (pl)
WO (1) WO2014026077A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013299487B2 (en) * 2012-08-10 2017-02-02 Sun Pharmaceutical Industries, Inc. Method for the treatment of acne
EP3082787B1 (en) 2013-12-20 2020-11-25 Galderma Research & Development Pulse photodynamic treatment of photodamaged skin
EP3362145B1 (en) 2015-10-15 2021-01-06 DUSA Pharmaceuticals, Inc. Adjustable illuminator for photodynamic therapy and diagnosis
US10357567B1 (en) 2018-01-12 2019-07-23 Dusa Pharmaceuticals, Inc. Methods for photodynamic therapy

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0831909B1 (en) * 1995-06-05 2005-01-26 Queen's University at Kingston Use of a protoporphyrin ix precursor in the treatment of dermatophytoses and malaria after photoactivation of said protoporphyrin
US6223071B1 (en) * 1998-05-01 2001-04-24 Dusa Pharmaceuticals Inc. Illuminator for photodynamic therapy and diagnosis which produces substantially uniform intensity visible light
JP2004506005A (ja) * 2000-08-16 2004-02-26 ザ　ジェネラル　ホスピタル　コーポレイション　ディー　ビー　エイ　マサチューセッツ　ジェネラル　ホスピタル 尋常性挫瘡用の局所アミノレブリン酸−光力学的治療
US7311722B2 (en) * 2001-01-22 2007-12-25 Eric Larsen Photodynamic stimulation device and methods
US7094228B2 (en) * 2001-07-31 2006-08-22 Zars, Inc. Methods and formulations for photodynamic therapy
US7018396B2 (en) * 2001-08-07 2006-03-28 New England Medical Center Hospitals, Inc. Method of treating acne
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
US20070179482A1 (en) * 2004-05-07 2007-08-02 Anderson Robert S Apparatuses and methods to treat biological external tissue
GB0424833D0 (en) * 2004-11-10 2004-12-15 Photocure Asa Method
AU2005330277A1 (en) * 2005-04-07 2006-10-12 Photo Diagnostic Devices (Pdd) Ltd Photosensitizers and MRI enhancers
GB0608315D0 (en) * 2006-04-27 2006-06-07 Univ St Andrews Light emitting device for use in therapeutic and/or cosmetic treatment
WO2008106966A1 (en) * 2007-03-06 2008-09-12 Christiansen Kaare A method for non-therapeutic or therapeutic photodynamic skin treatment
WO2009093144A2 (en) * 2008-01-25 2009-07-30 Qlt, Inc.Lau Photodynamic therapy of sebaceous gland disorders
US20090259167A1 (en) * 2008-04-04 2009-10-15 The General Hospital Corporation Methods and compositions for dose-dependent photodynamic therapy of disorders
US20100100083A1 (en) * 2008-10-22 2010-04-22 Scott Lundahl Method of treatment for dermatologic disorders
US8927761B2 (en) * 2012-06-28 2015-01-06 Photocure Asa Form of hexyl-5-aminolevulinate hydrochloride and methods of using the same
AU2013299487B2 (en) * 2012-08-10 2017-02-02 Sun Pharmaceutical Industries, Inc. Method for the treatment of acne
EP2884975B1 (en) * 2012-08-16 2019-07-31 Dusa Pharmaceuticals, Inc. Phototherapeutic agent for use in a method of treating onychomycosis
US20140067024A1 (en) * 2012-08-30 2014-03-06 Photocure Asa Dual panel photodynamic therapy lamp

Also Published As

Publication number Publication date
WO2014026077A1 (en) 2014-02-13
ES2778031T3 (es) 2020-08-07
AU2013299487A1 (en) 2015-02-26
US20160317831A1 (en) 2016-11-03
US9387341B2 (en) 2016-07-12
US20140046289A1 (en) 2014-02-13
US10029116B2 (en) 2018-07-24
CA2881439C (en) 2017-08-29
EP2882432B1 (en) 2020-02-12
CA2881439A1 (en) 2014-02-13
AU2013299487B2 (en) 2017-02-02
EP2882432A4 (en) 2016-04-06
EP2882432A1 (en) 2015-06-17

Similar Documents

Publication Publication Date Title
IL237791B (en) A method for treating cancer
SG11201503893RA (en) Method of treating cancer
SG10201610887WA (en) Methods of treating arthritis
SG10201701181XA (en) Methods of treating a tauopathy
EP2879689A4 (en) METHOD FOR THE TREATMENT OF ATHEROSCLEROSIS
EP2895206A4 (en) METHOD FOR TREATING CARCINOMA
EP2852559A4 (en) METHOD OF TREATING MUD
EP2855366A4 (en) PROCESS FOR TREATING WATER
SG11201504957RA (en) Water treatment method
ZA201408052B (en) Method for treating oily skin
PL2691103T3 (pl) Metoda leczenia zaburzeń skóry
EP2816126A4 (en) THERMAL TREATMENT METHOD
GB201205911D0 (en) Hair treatment method
HUE038149T2 (hu) Eljárás acél kezelésére
PL2855475T3 (pl) Alfa-karboliny do leczenia nowotworu
GB201215942D0 (en) Method of treatent
GB201105523D0 (en) Treatment method
GB201121950D0 (en) Treatment process
ZA201407215B (en) Method for emulsion treatment
EP2813798A4 (en) METHOD OF EXPLOSION TREATMENT
AP2015008271A0 (en) Method for producing an agent for the treatment oftuberculosis
GB201221032D0 (en) Method of treatment
GB201207894D0 (en) Method of treatment
AU2012905617A0 (en) Treatment method
AU2012905240A0 (en) Method of Treatment